Lisa Keenan joins the ALLG Board of Directors
The Australasian Leukaemia & Lymphoma Group (ALLG) warmly welcomes Ms Lisa Keenan to the ALLG Board of Directors.
An accountant by training, Lisa is a trusted adviser to boards and executive teams in Australia and overseas on matters that have the potential to impact the reputation of an organisation or its leadership. She is also a respected executive search consultant with a focus on the roles that govern reputation, at board level, in senior executive roles and in corporate affairs and investor relations. In addition, Lisa has run Corporate Affairs for a top ASX-listed company and founded and developed several successful businesses.
Commenting on her appointment Lisa Keenan said,
“I feel hugely privileged to be joining the board of the ALLG, an organisation whose purpose and achievements I greatly admire and respect. I look forward to contributing my energy and passion towards the ALLG’s vision of achieving global impact in the delivery of robust services and innovative outcomes to improve the treatments and lives of patients with blood cancer.”
In her ALLG Director role, Lisa will lead the Marketing Committee of the ALLG Board and provide strategic direction for the ALLG. She joins an exemplary group in the ALLG Board, including Mr Peter T. Kempen AM (Chair), Prof Peter Browett, Ms Geraldine Gray, Mr Malcolm McComas, A/Prof Peter Mollee, Ms Tina Rankovic, Prof Andrew Roberts and Prof Philip Rowlings.